Heron Neutron Medical Corp. logo

Heron Neutron Medical Corp. (7799)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
359. 00
+1
+0.2793%
NT$
50.24B Market Cap
- P/E Ratio
- Div Yield
203,589 Volume
- Eps
NT$ 358
Previous Close
Add Transaction
Day Range
347 360
Year Range
300 932
Want to track 7799 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7799 closed today higher at NT$359, an increase of 0.2793% from yesterday's close, completing a monthly increase of 1.844% or NT$6.5. Over the past 12 months, 7799 stock lost -20.7506%.
7799 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

7799 Chart

Heron Neutron Medical Corp. (7799) FAQ

What is the stock price today?

The current price is NT$359.00.

On which exchange is it traded?

Heron Neutron Medical Corp. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 7799.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 50.24B.

Has Heron Neutron Medical Corp. ever had a stock split?

No, there has never been a stock split.

Heron Neutron Medical Corp. Profile

- Industry
- Sector
- CEO
TWSE Exchange
- ISIN
Taiwan Country
104 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Heron Neutron Medical Corp. is a pioneering healthcare technology company established in 2016 and based in Zhubei, Taiwan. The company specializes in the development, manufacture, and integration of advanced medical equipment, primarily focusing on accelerator-based boron neutron capture therapy (AB-BNCT) systems. These innovative solutions are meticulously designed to provide precise and effective treatments for cancer by employing advanced technologies in neutron source targets, accelerators, beam shaping, treatment control, and planning. A notable aspect of Heron Neutron Medical Corp. is its comprehensive approach as a solution provider; not only does the company develop cutting-edge AB-BNCT devices, but it also integrates boron-containing therapeutic agents. This allows Heron Neutron Medical Corp. to deliver coordinated device-and-drug solutions tailored specifically for hospitals and research institutions, ultimately enhancing clinical efficiency, enabling more precise tumor targeting, reducing side effects when compared to conventional methods, and streamlining the overall patient care experience.

Products and Services

  • Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Systems

    Heron Neutron Medical Corp. specializes in advanced AB-BNCT systems that utilize neutron beams to target and treat cancer cells effectively. The technology leverages the unique properties of boron-10 isotopes, which, when exposed to thermal neutrons, produce high-energy alpha particles that selectively destroy tumor cells while sparing surrounding healthy tissues.

  • Boron-Containing Therapeutic Agents

    The company integrates boron-containing agents into its treatment protocols, creating synergistic effects with its AB-BNCT systems. These agents enhance the uptake of boron in tumor cells, thereby improving the efficacy of neutron capture therapy and facilitating better treatment outcomes.

  • Beam Shaping Technologies

    Heron Neutron Medical Corp. employs state-of-the-art beam shaping technologies to focus neutron beams precisely on tumors, minimizing the exposure of healthy tissues to radiation. This innovation aids in achieving optimal dose distribution and maximizes therapeutic impact.

  • Treatment Control and Planning Systems

    To ensure accuracy and efficacy, the company offers advanced treatment control and planning systems. These systems aid clinicians in strategizing and personalizing treatment plans based on the specific characteristics of each patient’s cancer, thus enhancing the overall treatment experience.

  • Clinical Collaboration and Support Services

    Heron Neutron Medical Corp. emphasizes collaboration with healthcare providers and research institutions. The company offers training, ongoing support, and consultation services to ensure the successful implementation and utilization of their AB-BNCT systems and related therapies.

Contact Information

Address: No. 66-2, Shengyi 5th Road
Phone: 886 3 561 9366